Comparison of subcostal transversus abdominis block with intraperitoneal instillation of bupivacaine and dexmedetomidine for pain relief after laparoscopic cholecystectomy, randomized double blinded controlled study

比较肋下腹横肌阻滞与腹腔内注射布比卡因和右美托咪定在腹腔镜胆囊切除术后镇痛效果的随机双盲对照研究

阅读:2

Abstract

BACKGROUND: This study compared the analgesic effectiveness of ultrasound-guided subcostal transversus abdominis plane (STAP) block with intraperitoneal instillation of bupivacaine and dexmedetomidine after LC. METHODS: This prospective, randomized, double-blind trial involved 60 ASA I-II patients undergoing elective LC. At random, the patients were divided into two groups of thirty each. Group 1 was given STAP block with bupivacaine and dexmedetomidine along with intraperitoneal normal saline. Bupivacaine, dexmedetomidine was administered intraperitoneally to Group 2 along with STAP with normal saline. The Numerical Rating Scale (NRS) was used to measure postoperative pain at rest, while coughing, and for shoulder tip discomfort as a primary outcome. Patient satisfaction, sedation rating, and time to first analgesic demand were also assessed as a secondary outcome. RESULTS: At rest and while coughing, Group 1's NRS ratings were considerably lower at all times (p < 0.001). Group 1 experienced considerably less shoulder tip discomfort 24 h after surgery (p = 0.032). Group 1 had a longer time to first analgesic demand (16.5 vs. 11.7 h, p = 0.003). By the end of the research, 12 patients in Group 1 needed postoperative analgesia (46.2% vs. 96.4%, p < 0.001). Group 1 had increased patient satisfaction (p < 0.001). CONCLUSION: STAP block offers better postoperative analgesia than intraperitoneal instillation. TRIAL REGISTRATION: This prospective interventional double-blinded clinical trial was done at Assiut University Hospitals, Assiut, Egypt, From June, 2021 to May, 2024. The study protocol was approved by the Institutional Review Board of the Faculty of Medicine, Assiut University (IRB approval number: 17200580) and registered with ClinicalTrials.gov (ID: NCT04715165).

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。